tiprankstipranks
Tryptamine Therapeutics Limited (AU:ENP)
ASX:ENP
Australian Market
Want to see AU:ENP full AI Analyst Report?

Compare Tryptamine Therapeutics (ENP) vs. Competitors

16 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Tryptamine Therapeutics
AU$63.64M
-10.19
5.56%
Amplia Therapeutics
AU$0.14
AU$77.00M
-3.83
115.38%
Actinogen Medical
AU$0.04
AU$147.24M
-4.28
63.64%
1 Buy
0 Hold
0 Sell
Moderate Buy
Neuren Pharmaceuticals Limited
AU$12.49
AU$1.62B
38.25
-6.37%
3 Buy
0 Hold
0 Sell
Strong Buy
Zelira Therapeutics
AU$0.34
AU$5.95M
-1.05
25.00%
Neuroscientific Biopharmaceuticals Ltd.
AU$0.10
AU$32.92M
-5.38
108.33%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:ENP
Tryptamine Therapeutics
0.04
<0.01
8.57%
AU:ATX
Amplia Therapeutics
0.14
0.09
174.51%
AU:ACW
Actinogen Medical
0.04
0.01
63.64%
AU:NEU
Neuren Pharmaceuticals Limited
12.35
-0.28
-2.22%
AU:ZLD
Zelira Therapeutics
0.50
0.09
21.95%
AU:NSB
Neuroscientific Biopharmaceuticals Ltd.
0.10
0.05
100.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts